PharmaTher Holdings Ltd.
PHRM
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.63% | -8.41% | -1.48% | 0.82% | -15.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.96% | -6.19% | -26.61% | -51.73% | -64.41% |
| Operating Income | 11.96% | 6.19% | 26.61% | 51.73% | 64.41% |
| Income Before Tax | 25.95% | 3.00% | 28.42% | 52.66% | 66.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.95% | 3.00% | 28.42% | 52.66% | 66.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.95% | 3.00% | 28.42% | 52.66% | 66.85% |
| EBIT | 11.96% | 6.19% | 26.61% | 51.73% | 64.41% |
| EBITDA | 62.48% | 41.73% | 42.36% | 51.74% | 64.41% |
| EPS Basic | 26.67% | 4.10% | 29.44% | 53.05% | 67.12% |
| Normalized Basic EPS | 21.43% | 0.00% | 22.55% | 50.00% | 63.54% |
| EPS Diluted | 26.67% | 4.10% | 29.44% | 53.05% | 67.12% |
| Normalized Diluted EPS | 21.43% | 0.00% | 22.55% | 50.00% | 63.54% |
| Average Basic Shares Outstanding | 2.23% | 1.62% | 0.81% | 0.23% | 0.26% |
| Average Diluted Shares Outstanding | 2.23% | 1.62% | 0.81% | 0.23% | 0.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |